drug
insulin degludec LA
Marketedupdated 5mo agoby Novo Nordisk Inc
Approvedcommunity read0 votes
🐶 often sniffed alongside
top 3indications
investigational
Type 2 Diabetes
all catalysts(0)
nothing on the calendar yet
Trials studying insulin degludec LA
- phase3A Research Study to Compare a New Weekly Insulin, Insulin Icodec Used With DoseGuide App, and Daily Insulins in People With Type 2 Diabetes Who Have Not Used Insulin Before
- phase1A Clinical Study to Evaluate the Pharmacokinetic and Pharmacodynamics Properties of of SHR-3167 in Subjects With Type 2 Diabetes
- phase2Evaluate the Efficacy and Safety of GZR101-80 Injection in Patients With Type 2 Diabetes
- phase3Evaluate the Efficacy and Safety of GZR33 Injection in Patients With Type 2 Diabetes
- phase1A Research Study of a New Medicine NNC0363-1063 in Healthy Participants and Participants With Type 1 Diabetes
- phase1A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)
- —A Research Study in Saudi Arabia to Understand How the Dose Check App Used With Tresiba Treatment Helps to Control Blood Sugar Level
- —Regulatory Post Marketing Surveillance (rPMS) Study of Xultophy® (Insulin Degludec/Liraglutide) to Evaluate Safety and Effectiveness in Patients With Type 2 Diabetes Mellitus in Routine Clinical Practice in Korea
News(1)
- Eli Lilly’s weekly insulin shot cleared by FDA, setting up another front in Novo rivalryThe weekly insulin Onswik will now be available to U.S. patients after initial approvals in Europe, Mexico and Japan.biospace · 7d ago
Data sources
last refreshed 4h ago
Found something off?
comments(0)
5-min edit window · permanent after that